Invitrogen™ Human ATG10 Synthetic Peptide
ATG10 Synthetic Peptide, PEP-0571, from Invitrogen.
- Gene ID (Enter)
- 83734
- Species
- Human
- Purification method
- Purified
- Accession number
- Q9H0Y0
- Common name
- Human ATG10
- Brand
- Invitrogen
ATG10 Synthetic Peptide, PEP-0571, from Invitrogen.
ATG10 Synthetic Peptide, PEP-0571, from Invitrogen.
ATG10 is involved in autophagy which is a process for the bulk degradation of cytosolic compartments by lysosomes/vacuoles. The formation of autophagosomes involves a dynamic rearrangement of the membrane for which two ubiquitin-like modifications (the conjugation of APG12p and the modification of a soluble form of MAP-LC3 to a membrane-bound form) are essential. APG10 is an E2-like enzyme involved in two ubiquitin-like modifications essential for autophagosome formation, ATG12 -ATG5 conjugation and modification of a soluble form of MAP-LC3 (MAP1LC3A), a homolog of yeast Apg8, to a membrane-bound form. The protein ATG10 is ubiquitously expressed and the human APG10L gene is localized on chromosome 5q14.2.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15318720 |
| Specifications | |
| Gene ID (Enter) | 83734 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q9H0Y0 |
| Common name | Human ATG10 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | ATG10 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-0571 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |